Ilumina joins a collaborative project to decode the COVID-19 immune response

20 Mar 2020

Illumina, have today announced that they are part of a new collaboration with Adaptive Biotechnologies Corp., Microsoft, LabCorp and Providence Health & Services to decode the COVID-19 immune response and to provide open access to data from the virtual clinical trial starting in April 2020.

Latest news

The Wellcome Sanger Institute has joined a major new international effort to build the open data foundations needed to accelerate ...

30 Apr 2026

Sequencing the DNA of all complex life in the UK and Ireland could generate up to almost £3 billion for ...

16 Apr 2026

One of the UK’s first autonomous vehicle routes could arrive in Cambridgeshire, as the Wellcome Genome Campus embarks on ...

13 Apr 2026